| 000 | 03024nam a22003977a 4500 | ||
|---|---|---|---|
| 008 | 170428s20172017 xxu||||| |||| 00| 0 eng d | ||
| 022 | _a1050-7256 | ||
| 040 | _aOvid MEDLINE(R) | ||
| 099 | _a28114862 | ||
| 245 | _aAmerican Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. | ||
| 251 | _aThyroid. 27(4):481-483, 2017 Apr | ||
| 252 | _aThyroid. 27(4):481-483, 2017 Apr | ||
| 253 | _aThyroid : official journal of the American Thyroid Association | ||
| 260 | _c2017 | ||
| 260 | _fFY2017 | ||
| 266 | _d2017-05-06 | ||
| 501 | _aAvailable online from MWHC library: August 2000 - present, Available in print through MWHC library: 1999 - 2006 | ||
| 520 | _aAmerican Thyroid Association (ATA) leadership asked the ATA Thyroid Nodules and Differentiated Thyroid Cancer Guidelines Task Force to review, comment on, and make recommendations related to the suggested new classification of encapsulated follicular variant papillary thyroid carcinoma (eFVPTC) without capsular or vascular invasion to noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). The task force consists of members from the 2015 guidelines task force with the recusal of three members who were authors on the paper under review. Four pathologists and one endocrinologist were added for this specific review. The manuscript proposing the new classification and related literature were assessed. It is recommended that the histopathologic nomenclature for eFVPTC without invasion be reclassified as a NIFTP, given the excellent prognosis of this neoplastic variant. This is a weak recommendation based on moderate-quality evidence. It is also noted that prospective studies are needed to validate the observed patient outcomes (and test performance in predicting thyroid cancer outcomes), as well as implications on patients' psychosocial health and economics. | ||
| 546 | _aEnglish | ||
| 650 | _a*Adenocarcinoma, Follicular/pa [Pathology] | ||
| 650 | _a*Carcinoma, Papillary/pa [Pathology] | ||
| 650 | _a*Terminology as Topic | ||
| 650 | _a*Thyroid Neoplasms/pa [Pathology] | ||
| 650 | _aHumans | ||
| 650 | _aNeoplasm Invasiveness | ||
| 650 | _aSocieties, Medical | ||
| 650 | _aThyroid Nodule | ||
| 650 | _aUnited States | ||
| 651 | _aMedStar Washington Hospital Center | ||
| 656 | _aMedicine/Endocrinology | ||
| 657 | _aJournal Article | ||
| 700 | _aWartofsky, Leonard | ||
| 790 | _aAlexander EK, Bible KC, Caturegli P, Doherty GM, Haugen BR, Mandel SJ, Morris JC, Nassar A, Pacini F, Sawka AM, Schlumberger M, Schuff K, Sherman SI, Somerset H, Sosa JA, Steward DL, Wartofsky L, Williams MD | ||
| 856 |
_uhttps://dx.doi.org/10.1089/thy.2016.0628 _zhttps://dx.doi.org/10.1089/thy.2016.0628 |
||
| 942 |
_cART _dArticle |
||
| 999 |
_c3173 _d3173 |
||